Regulatory News, Stories, and Features

How FDA Investigators Pinpointed Cause of Illness Tied to Nutrition Shakes at Long-Term Care Facilities
Bound by scientific integrity and transparency, the FDA is tasked with gathering clear evidence (for instance, a sample taken from a food production line that test positive for E. coli) to determine if the facility could be the source of contamination and then what action it should take to protect the public.
With Broad Appeal, FDA’s Workshop on Reducing Animal Testing Hears from Experts on More Humane and Human-Relevant Testing Methods
Scientists and regulators unite to advance testing methods that are both more humane and more scientifically accurate—discover the innovative alternatives reshaping drug safety research.
Independent Panel Evaluates Safety of Talc in Everyday Products to Protect Public Health
Learn more about what a group of independent scientists from different countries found when they looked into whether talc is safe and needed in foods, medicines, and beauty products.
Division of Targeting and Analysis Embraces Greater Challenges, Stronger Collaborations
Discover how OII’s Division of Targeting and Analysis works around the clock to help stop harmful or contaminated FDA-regulated products from reaching the public.

Sub-Topic Paragraphs